Imagine a world where the complex dance of molecules within cells is visible, driving advancements in antibiotics, neurodegenerative treatments, and virus therapies. Rizer Biotech is a KTH spinoff that has developed a new optical measurement technique, published in Nature Biotechnology, providing revolutionizing scientific insights for drug discovery and therapeutic research.

Please see the full ad and submit your application through

https://emp.jobylon.com/jobs/226371

Accomplishments

The founding team has developed the measurement technology over the last 5 years culminating in a high-impact publication in Nature Biotechnology. Within the last 12 months, the team has also:

• Secured 4.8 MSEK in academic proof-of-concept funding.

• Secured an investment from KTH Holding and initiated contact with other external funding sources.

• Initiated market validation confirming interest from pharma players.

• Filed patents in key covering the essential technological innovation.

Our next CEO

We are seeking an individual with the drive and capability to take the helm of Rizer Biotech and enable us to fully harness the large potential of the technology. As CEO you will build the foundation for the company, and lead business and team development. You will develop and explore potential business models and strategies and your role will be instrumental in shaping the trajectory of Rizer Biotech.

We will offer an initial onboarding period (4-6 months) where you will be hired under a consulting assignment funded by KTH Innovation/KTH Holding to validate the business, devise a commercial roadmap and get some traction. Thereafter, the intention is for you to become a co-founder of the company with incentives for long-term commitment in the form of equity and option programs. You should be committed to dedicating your time to this startup at a significant level (increasing with time and funding situation).